Elsevier, Journal of Investigative Dermatology, 1(130), p. 12-14, 2010
DOI: 10.1038/jid.2009.332
Full text: Download
In this issue, Hacker and colleagues provide further evidence that molecular subtypes of malignant melanoma may develop along divergent pathways. The authors did not find an association between somatic BRAF-mutant melanoma and germline melanocortin-1 receptor (MC1R) gene status. We discuss this seeming paradox in light of previous studies demonstrating strong associations.